Bimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativa ACoP15 (Nov 2024), Poster: T-041 Jönsson S, Gallais F, Janssen JM, Rolleri R, Khandelwal A, Dua P, Sidhu J. ConferenceInflammationPharmacometricsProgram strategies and efficiencies Pharmetheus Affiliates Senior Director, R&D Scientist Siv Jönsson See bio Senior Director, MIDD Consultant Fanny Gallais See bio Senior Director, MIDD Consultant Julie Janssen See bio Director, Quality Control & Medical Writing Consultant Viviana Moroso See bio
